![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
8 episodes
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Melody.education: Educational programs on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD) Melody.education
-
- Health & Fitness
-
-
5.0 • 1 Rating
-
www.Melody.education is the premier, online central source and community wherein multidisciplinary healthcare providers deliver and experience the most up-to-date information, data and resources on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD). With our Clinical Experts Faculty we produce: Webconferences, Strategies for Optimal Outcomes, Case Studies, Audience Questions and Faculty Answers.
-
Prof Michael Trauner presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Welcome and Introduction
Part 1: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Welcome and Introduction with Prof Michael Trauner
-
Prof Jörn Schattenberg presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: NASH: A Growing Unmet Therapeutic Need
Part 2: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: NASH: A Growing Unmet Therapeutic Need with Prof Jörn Schattenberg
-
Prof Meena Bansal, MD presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: The Underestimated Importance of Thyroid Hormone Pathway in the Pathophysiology of NASH
Part 3: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: The Underestimated Importance of Thyroid Hormone Pathway in the Pathophysiology of NASH with Prof Meena Bansal, MD
-
Prof Michael Trauner presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Closing
Part 4: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Closing with Prof Michael Trauner
-
Scott Isaacs, MD, FACE, FACP and Barton Isaac, PharmD present: NASH Patient Identification, Referral and Management in Endocrinology and Hepatology Practices
NASH Patient Identification, Referral and Management in Endocrinology and Hepatology Practices with Scott Isaacs, MD, FACE, FACP and Barton Isaac, PharmD
-
Keith Miller, PhD presents: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD): Introduction
Part 1: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD): Introduction with Keith Miller, PhD